Traxium T 250mg/31.25mg Injection
Marketer
Novique Life Sciences
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Traxium T 250mg/31.25mg Injection
Combiflox 250mg/31.25mg Injection is a dual-action antibiotic used to combat diverse bacterial infections. It inhibits microbial proliferation, thereby limiting infection spread. Administration must be overseen by a physician. Consistent adherence to the prescribed schedule is crucial; complete the entire course, regardless of symptom improvement. Premature cessation can compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately to your doctor. Seek prompt medical attention for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration contribute to faster recovery. Your doctor may order lab tests to monitor treatment response.
Primary Ingredients of Traxium T 250mg/31.25mg Injection
The provided text is "undefined," so no rewriting is possible.
Uses of Traxium T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Traxium T 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Traxium T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Traxium T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Traxium T 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam injection (Traxium T 250mg/31.25mg) unites two active agents. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering bacterial growth and survival. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent ingestion of alcohol and Traxium T 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Traxius T, containing 250mg/31.25mg, is typically deemed safe for use in pregnancy. Preclinical trials using animals revealed minimal or absent harmful effects on fetal development; the data from human trials, however, remains limited.
Breast feedingCAUTION
Administration of Traxius T 250mg/31.25mg Injection necessitates prudence while breastfeeding. Lactation should be temporarily discontinued throughout maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
The administration of Traxium T 250mg/31.25mg Injection can lead to drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Traxium T 250mg/31.25mg Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The injectable medication, Traxium T 250mg/31.25mg, requires careful administration in individuals with advanced hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Traxium T 250mg/31.25mg Injection is not suggested for patients experiencing mild or moderate liver dysfunction.
What if you forget to take Traxium T 250mg/31.25mg Injection :
Should you inadvertently omit a scheduled dose of Traxium T 250mg/31.25mg Injection, seek immediate medical advice.
Facts to Know About Traxium T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently